{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products CRBM Slides",
        "VITROS Chemistry Products CREA Slides",
        "VITROS Chemistry Products TBIL Slides",
        "VITROS XT 7600 Integrated System"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K182063",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160495",
        "K063591",
        "K840880",
        "K081543"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KLT",
        "JFY",
        "CIG",
        "JJE"
    ],
    "Summary Letter Date": "July 30, 2018",
    "Summary Letter Received Date": "August 1, 2018",
    "Submission Date": "July 30, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3645",
        "21 CFR 862.1225",
        "21 CFR 862.1110",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Neuroleptic drugs radioreceptorassay test system",
        "Creatinine test system",
        "Bilirubin (total or direct) test system",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Carbamazepine",
        "Creatinine",
        "Total bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid",
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "Cups",
        "Primary Sample Collection Tubes"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS 250 Chemistry System",
        "VITROS 350 Chemistry System",
        "VITROS 950 Chemistry System",
        "VITROS 5,1 FS Chemistry System",
        "VITROS 4600 Chemistry System",
        "VITROS 5600 Integrated System",
        "VITROS XT 7600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Potentiometric assay",
        "Enzymatic endpoint assay",
        "Immunorate assay",
        "Dual wavelength endpoint",
        "Reflection densitometry",
        "Transmission spectrophotometry"
    ],
    "Methodologies": [
        "Multiple-point Immunorate",
        "Two-point rate",
        "Dual wavelength endpoint",
        "Automated chemistry analyzer"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "System",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS XT 7600 Integrated System and associated CRBM, CREA, and TBIL assays for clinical chemistry measurement using colorimetric, enzymatic and immunorate methods",
    "Indications for Use Summary": "Quantitative measurement of carbamazepine in serum/plasma, creatinine in serum/plasma/urine, and total bilirubin in serum/plasma, with intended use for therapeutic monitoring, renal and liver disease diagnosis/treatment, and multiparameter clinical chemistry analysis.",
    "fda_folder": "Clinical Chemistry"
}